Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
phase 3
Articles
3
From
2026-07-22 12:30:00+00
To
2026-08-12 04:57:22+00
Range
2026-07-14 00:05:58.780833+00 →
2026-08-13 00:05:58.780833+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| phase 3 | PRODUCT | 3 | 📊 🔍 🧲 |
| fda | ORG | 2 | 📊 🔍 🧲 |
| 1 billion | MONEY | 1 | 📊 🔍 🧲 |
| 15 million | MONEY | 1 | 📊 🔍 🧲 |
| 5 million | MONEY | 1 | 📊 🔍 🧲 |
| accelerated approval | ORG | 1 | 📊 🔍 🧲 |
| adcom | PRODUCT | 1 | 📊 🔍 🧲 |
| adcoms | ORG | 1 | 📊 🔍 🧲 |
| agency | ORG | 1 | 📊 🔍 🧲 |
| ai readiness starts | ORG | 1 | 📊 🔍 🧲 |
| alex sveda | PERSON | 1 | 📊 🔍 🧲 |
| alon bennoon | PERSON | 1 | 📊 🔍 🧲 |
| als | ORG | 1 | 📊 🔍 🧲 |
| als news | ORG | 1 | 📊 🔍 🧲 |
| annex clinical corporation | ORG | 1 | 📊 🔍 🧲 |
| biospace | ORG | 1 | 📊 🔍 🧲 |
| bla | ORG | 1 | 📊 🔍 🧲 |
| cambridge | GPE | 1 | 📊 🔍 🧲 |
| canada | GPE | 1 | 📊 🔍 🧲 |
| canadian | NORP | 1 | 📊 🔍 🧲 |
| capricor | ORG | 1 | 📊 🔍 🧲 |
| capricor therapeutics | PERSON | 1 | 📊 🔍 🧲 |
| casper | GPE | 1 | 📊 🔍 🧲 |
| casper business center | ORG | 1 | 📊 🔍 🧲 |
| casper financial services | ORG | 1 | 📊 🔍 🧲 |
Who’s talking
Top Sources (Domains)
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 33.33 | 📊 📰 🧲 |
|
|
1 | 33.33 | 📊 📰 🧲 |
|
|
1 | 33.33 | 📊 📰 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-08-12 04:57:22+00 | Business |
|
Casper City Council plans financing for final phase of business center remodel | Analyze | Tommy Culkin | 😐 neutral | 0.0807 |
| 2026-08-04 07:38:14+00 | Science |
|
Capricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics. | Analyze | Moe Alsumidaie | 😐 neutral | 0.0249 |
| 2026-07-22 12:30:00+00 | Health |
|
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS | Analyze | NeuroSense | 😐 neutral | 0.0959 |